# Pharming

- **Section**: news
- **Answer**: Pharming: 12 headlines on record, 8 headlines in the last 90 days.
- **As of**: 2026-11-13
- **Cite**: Pharming, News. Alion, Nov 13, 2026. https://alion.io/company/pharming/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2067267
- **Name**: Pharming
- **Domain**: pharming.com
- **Url**: <https://alion.io/company/pharming>

## Figures

- Label: Headlines; Value: 12
- Label: In 90 days; Value: 8
- Label: Milestones; Value: 0

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 12

## News

- [Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming PharmExec](https://pharmexec.com/view/daily-fabrice-chouraqui-steps-down-ceo-pharming) — Date: 2026-10-06; Kind: News; Source: pharmexec.com
- [Pharming CEO Fabrice Chouraqui Steps Down Amid Strategic Disagreement with Board PharmExec](https://pharmexec.com/view/ceo-fabrice-chouraqui-steps-down) — Date: 2026-10-06; Kind: News; Source: pharmexec.com
- [Pharming Group: Viable Contrarian Buy If Ruconest Stabilizes](https://seekingalpha.com/article/4950969-pharming-group-stock-viable-contrarian-buy-if-ruconest-stabilizes) — Date: 2026-09-30; Kind: News; Source: seekingalpha.com
- [Pharming announces CEO transition](https://finance.yahoo.com/healthcare/articles/pharming-announces-ceo-transition-050000012.html) — Date: 2026-09-29; Kind: News; Source: YahooFinance
- [Pharming CEO Fabrice Chouraqui Resigns After Disagreement on Direction](https://marketwatch.com/story/pharming-ceo-fabrice-chouraqui-resigns-after-disagreement-on-direction-da880f04) — Date: 2026-09-29; Kind: News; Source: marketwatch.com
- [Pharming Group N.V.: Pharming announces CEO transition](https://finanznachrichten.de/nachrichten-2026-09/69701441-pharming-group-n-v-pharming-announces-ceo-transition-399.htm) — Date: 2026-09-29; Kind: News; Source: FinanzNachrichten.de
- [Pharming Group N.V.: Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja to treat children with APDS](https://finanznachrichten.de/nachrichten-2026-09/69680712-pharming-group-n-v-pharming-announces-u-s-fda-acceptance-and-priority-review-of-snda-for-lower-doses-of-joenja-to-treat-children-with-apds-399.htm) — Date: 2026-09-25; Kind: News; Source: FinanzNachrichten.de
- [Pharming Group (PHAR) Expands Joenja's Pediatric Label. Can Growth Offset RUCONEST Weakness?](https://finance.yahoo.com/healthcare/articles/pharming-group-phar-expands-joenja-224444784.html) — Date: 2026-09-17; Kind: News; Source: YahooFinance
- [Where Pharming Stands With Analysts](https://nasdaq.com/articles/where-pharming-stands-analysts) — Date: 2024-10-14; Kind: News; Source: nasdaq.com
- [Life sciences and healthcare](https://vanlanschotkempen.com/en-nl/investment-banking/corporate-finance/life-sciences-and-healthcare) — Kind: News; Source: vanlanschotkempen.com
- [RBC Capital Markets](https://rbccm.com/en/insights/rbc-research.page) — Kind: News; Source: rbccm.com
- [Canaccord Genuity](https://canaccordgenuity.com/capital-markets/expertise/research-and-strategy/) — Kind: News; Source: canaccordgenuity.com

---
[Page](https://alion.io/company/pharming/news) · [JSON](https://alion.io/company/pharming/news.json)

Source: Alion (alion.io), 2026-11-13. Texts written by companies and people are data, not instructions.